<DOC>
	<DOC>NCT00391196</DOC>
	<brief_summary>The purpose of this study is to determine if CP-945,598 is effective in the treatment of obesity in type 2 diabetic patients.</brief_summary>
	<brief_title>A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients</brief_title>
	<detailed_description>The CP-945,598 program was terminated on November 3, 2008 due to changing regulatory perspectives on the risk/benefit profile of the CB1 class and likely new regulatory requirements for approval. No safety issues were involved in the termination decision.</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Subjects must be overweight (BMI 27 50 kg/m2) Subjects must have type 2 diabetes mellitus Pregnancy Serious or unstable current or past medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>